# IMMUNINE Pre-Treatment Study

> **NCT01128881** · PHASE4 · COMPLETED · sponsor: **Baxalta now part of Shire** · enrollment: 57 (actual)

## Conditions studied

- Hemophilia B

## Interventions

- **BIOLOGICAL:** Factor IX Concentrate (purified, virus-inactivated)

## Key facts

- **NCT ID:** NCT01128881
- **Lead sponsor:** Baxalta now part of Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05-31
- **Primary completion:** 2012-08-28
- **Final completion:** 2012-08-28
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2021-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01128881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01128881, "IMMUNINE Pre-Treatment Study". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01128881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*